CEO Mike Mahoney said the upcoming years will be a time of restructuring for Boston Scientific, following layoffs and ...

Eurofins Scientific updated its 2026 guidance after weaker than usual market conditions and cancelled clinical programmes, ...

Through the Young Researchers Institute Fellowship, students are learning how AI can expand access to scientific research, ...

Boston Scientific cuts Q4 guidance as cyberattack fallout and EP and Watchman market pressures weigh on growth heading into ...

EVERSANA has acquired Estima Scientific, a London-based health economics and outcomes research technology and services ...

Boston Scientific has seen its stock drop 55% over the last year, and today's double dose of bad news didn't help things. The product recall is tied to the company's ENROUTE Transcarotid ...

Omabit, a company developing AI to support scientific decision-making, today announced $2 million in seed financing led by Bright Ventures. Omabit integrates a life science company’s own genomic, ...

The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts ...

Boston Scientific stock crashed Wednesday after the medtech giant cut its outlook in the wake of a cybersecurity incident.

Boston Scientific Corp BSX on Wednesday posted upbeat third-quarter financial results and cut its FY26 guidance below ...

The citations at the end of a research paper should represent a solid foundation of existing knowledge about a particular field, a pool of peer-reviewed sources built over years of research and study.

Boston Scientific’s weak outlook, cyberattack disruptions, and slowing Watchman and electrophysiology growth weighed on sentiment.